CP c.1292C>T ;(p.A431V)

Variant ID: 3-148919945-G-A

NM_000096.3(CP):c.1292C>T;(p.A431V)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

Plos One
Sutherland, Katherine A KA; Parry, Chris M CM; McCormick, Adele A; Kapaata, Anne A; Lyagoba, Fred F; Kaleebu, Pontiano P; Gilks, Charles F CF; Goodall, Ruth R; Spyer, Moira M; Kityo, Cissy C; Pillay, Deenan D; Gupta, Ravindra K RK; ,
Publication Date: 2015

Variant appearance in text: CP: A431V
PubMed Link: 26382239
Variant Present in the following documents:
  • Main text
  • pone.0137834.pdf
View BVdb publication page